Drug major GlaxoSmithKline Plc (GSK) has increased stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare Ltd to 72.5 per cent in a transaction worth Rs 4,800 crore (Rs 48 billion).In a......
GlaxoSmithKline Consumer Healthcare on Tuesday said the multi-billion dollar global deal between parent GlaxoSmithKline Plc and Swiss drug major Novartis won't affect its business in India. The two......
GlaxoSmithKline Plc is likely to raise stake in its Indian arm to 51 per cent through a buyback plan. At present, the Indian arm, GlaxoSmithKline Consumer Healthcare is an associate company of the......
Deviating from the global business strategy of its UK parent, GlaxoSmithKline Pharmaceuticals India, the largest multinational drugs company in the country, is planning to sell in India drugs that......
Nicholas Piramal India, one of the leading pharmaceutical companies, is likely to sign a third party manufacturing contract with the global pharmaceutical leader GlaxoSmithKline for its avian flu......